[1]宋 巍,姚 虹,王 罡,等.乳腺癌的钼靶X线征象与免疫组化标记物表达的关系[J].医学信息,2019,32(18):59-62.[doi:10.3969/j.issn.1006-1959.2019.18.019]
　SONG Wei,YAO Hong,WANG Gang,et al.Relationship between X-ray and Expression of Immunohistochemical Markers in Breast Cancer[J].Journal of Medical Information,2019,32(18):59-62.[doi:10.3969/j.issn.1006-1959.2019.18.019]
点击复制

乳腺癌的钼靶X线征象与免疫组化标记物表达的关系()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年18期
页码:
59-62
栏目:
论著
出版日期:
2019-09-15

文章信息/Info

Title:
Relationship between X-ray and Expression of Immunohistochemical Markers in Breast Cancer
文章编号:
1006-1959（2019）18-0059-04
作者:
宋 巍; 姚 虹; 王 罡; 安鸿飞; 李沁怡
云南省第一人民医院/昆明理工大学附属昆华医院放射科，云南 昆明 650032
Author(s):
SONG Wei; YAO Hong; WANG Gang; AN Hong-fei; LI Qin-yi
Yunnan First People's Hospital/Department of Radiology,Kunhua Hospital,Kunming University of Science and Technology, Kunming 650032,Yunnan,China
关键词:
乳腺癌; 肿块; 局限性致密浸润影; 免疫组化标记物
Keywords:
Key words：Breast cancer; Mass; Localized dense infiltrates; Immunohistochemical markers
分类号:
R737.9
DOI:
10.3969/j.issn.1006-1959.2019.18.019
文献标志码:
A
摘要:
目的 分析乳腺癌的主要X线征象，肿块、局限性致密浸润影与病理检测常用的免疫组化标记物ER，PR，C-erbB-2，nm23之间的关系。方法 收集云南省第一人民医院2016年1月~2019年1月经病理证实107例乳腺癌患者作为研究对象，病灶共108例，所有患者均行钼靶X线摄影。根据X线征象将所有病灶分为肿块组73例及局限性致密影组35例。使用免疫组化技术测定乳腺癌ER，PR，C-erbB-2，nm23的表达水平，比较两组癌灶中基因表达水平。结果 乳腺癌钼靶X线征象表现为局限性致密浸润影组（80.00%）C-erbB-2的表达高于肿块组（56.16%），差异有统计学意义（P＜0.05）；局限性致密浸润影组（40.00%）nm23高表达者低于肿块组（64.38%），差异有统计学意义（P＜0.05）；局限性致密浸润影组腋窝淋巴结转移多于肿块组（P＜0.05）；肿块和局限性致密浸润影其ER，PR阳性表达比较，差异均无统计学意义（P＞0.05）。结论 乳腺癌主要X线征象的差异可反映肿瘤细胞基因表达C-erbB-2与nm23水平，针对乳腺癌具体征象分析对于其早期诊断及其预后的初步判断有一定意义。
Abstract:
Abstract：Objective To analyze the relationship between the main X-ray signs of breast cancer, tumors, localized dense infiltrates and immunological standardization markers ER, PR, C-erbB-2, nm23 commonly used in pathological examination.Methods A total of 107 patients with breast cancer were enrolled in the First People's Hospital of Yunnan Province from January 2016 to January 2019. The lesions were 108 patients. All patients underwent mammography. According to X-ray signs, all lesions were divided into 73 cases of mass group and 35 cases of localized dense shadow group. The expression levels of ER, PR, C-erbB-2 and nm23 in breast cancer were determined by immunohistochemistry, and the gene expression levels in the two groups were compared. Results The mammography of mammography showed that the expression of C-erbB-2 was higher in the localized dense infiltration group (80.00%) than in the mass group (56.16%),the difference was statistically significant (P<0.05); localized dense In the infiltration group (40.00%), the high expression of nm23 was lower than that of the mass group (64.38%), the difference was statistically significant (P<0.05); the localized dense infiltration group had more axillary lymph node metastasis than the mass group (P<0.05); There was no significant difference in the positive expression of ER and PR between the lumps and localized dense infiltrates (P>0.05).Conclusion The difference of main X-ray signs of breast cancer can reflect the expression of C-erbB-2 and nm23 in tumor cells. The analysis of specific signs of breast cancer has certain significance for the early diagnosis and prognosis.

参考文献/References:

[1]Kandalaft PL,Chang KL,Ahn CW,et al.Prognostic significance of immunohistochemical analysis of cathepsin D in low-stage breast cancer[J].Cancer,2015,71(9):2756-2763. [2]Verbeek BS,Vroom TM,Adriaansen-Slot SS,et al.c-Src protein expression is increased in human breast cancer.An immunohistochemical and biochemical analysis[J].Journal of Pathology,2015,180(4):383-388. [3]Conlon N,Sadri N,Corben AD,et al.Acinic cell carcinoma of breast:morphologic and immunohistochemical review of a rare breast cancer subtype[J].Human Pathology,2016(51):16-24. [4]Sun WY,Yu KL,Koo JS.Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies[J].Journal of Translational Medicine,2016,14(1):173. [5]王红莉,赖建国,顾然,等.第五版BI-RADS对乳腺X线可疑钙化评估分类的临床应用[J].中山大学学报(医学版),2019, 40(1):76-82. [6]Cetin Sorkun H,Akbulut M,Enli Y,et al.Quantitative comparison of immunohistochemical and PCR analysis of midkine expression in breast cancer types and serum midkine level[J].Turkish Journal of Medical Sciences,2016,46(1):219. [7]Zarella MD,Heintzelman RC,Popnikolov NK,et al.BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast cancer recurrence score[J].BMC Clinical Pathology,2018,18(1):14. [8]Boudin L,Chabannon C,Sabatier R,et al.High-dose chemotherapy for inflammatory breast cancer: impact of immunohistochemical status on survival outcome[J].Annals of Oncology,2016,27(suppl_6):297. [9]Bassam AM,Abdel-Salam LO,Khairy DA.Immunohistochemical Evaluation Of ALK Expression In Breast Cancer[J].Ndt&E International,2016,27(221):288. [10]邓小明,姚尚龙,于布为,等.现代麻醉学[M].第4版.北京:人民卫生出版社,2014:754. [11]Bonneterre J,Bosq J,Jamme P,et al.Tumour and cellular distribution of activated forms of PR in breast cancers:a novel immunohistochemical analysis of a large clinical cohort[J].Esmo Open,2016,1(4):e000072. [12]Effi AB,Aman NA,Koui BS,et al.Immunohistochemical determination of estrogen and progesterone receptors in breast cancer:relationship with clinicopathologic factors in 302 patients in Ivory Coast[J].BMC Cancer,2017,17(1):115. [13]Tang H,Huang X,Wang J,et al.circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer[J].Molecular Cancer,2019,18(1):23. [14]Wang M,Liang L,Lu J,et al.Delanzomib,a novel proteasome inhibitor,sensitizes breast cancer cells to doxorubicin‐induced apoptosis[J].Thoracic Cancer,2019. [15]Li X,Radulovic M,Kanjer K,et al.Discriminative Pattern Mining for Breast Cancer Histopathology Image Classification via Fully Convolutional Autoencoder[J].IEEE Access,2019:1. [16]Wu Z,Zhang L,Xu S,et al.Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy[J].Cancer Cell International,2019,19(1).

相似文献/References:

[1]董 云.SPECT/CT 双时相99mTc- MIBI断层显像 在乳腺癌诊断中的应用[J].医学信息,2018,31(05):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
　DONG Yun.Application of SPECT/CT Dual-phase 99mTc-MIBI Tomography in the Diagnosis of Breast Cancer[J].Journal of Medical Information,2018,31(18):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
[2]张 虎,张 涛,徐 芳,等.MRI在乳腺癌诊治中的研究进展[J].医学信息,2022,35(10):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
　ZHANG Hu,ZHANG Tao,XU Fang,et al.Research Progress of MRI in Diagnosis and Treatment of Breast Cancer[J].Journal of Medical Information,2022,35(18):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
[3]李建辉,祝旭龙.乳腺癌的治疗管理——把好生活质量关[J].医学信息,2018,31(13):1.[doi:10.3969/j.issn.1006-1959.2018.13.001]
[4]杨玉峰,李 强,曲国红,等.乳腺癌术前巴德枪穿刺检测ER、PR的临床研究[J].医学信息,2018,31(13):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
　YANG Yu-feng,LI Qiang,QU Guo-hong,et al.Clinical Study on Preoperative ER and PR Detection of Bard Gun Puncture in Breast Cancer[J].Journal of Medical Information,2018,31(18):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
[5]刘雪静,路 红,徐熠琳,等.乳腺影像与容积导航技术初步应用的临床分析[J].医学信息,2022,35(11):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
　LIU Xue-jing,LU Hong,XU Yi-lin,et al.Clinical Analysis of the Preliminary Application of Breast Imaging and Volume Navigation Technology[J].Journal of Medical Information,2022,35(18):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
[6]刘在波,修文娟.背阔肌皮瓣联合假体在乳腺癌改良根治术后乳房重建中的应用[J].医学信息,2019,32(02):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
　LIU Zai-bo,XIU Wen-juan.Application of Latissimus Dorsi Flap Combined with Prosthesis in Breast Reconstruction after Modified Radical Mastectomy for Breast Cancer[J].Journal of Medical Information,2019,32(18):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
[7]孟庆国,王佳雪,王斯佳.马来酸吡咯替尼对乳腺癌术后患者心脏功能的影响[J].医学信息,2019,32(02):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
　MENG Qing-guo,WANG Jia-xue,WANG Si-jia.Effect of Pyrrolidine Maleate on Cardiac Function in Patients after Breast Cancer Operation[J].Journal of Medical Information,2019,32(18):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
[8]刘 曼,厉玛倩倩,徐润润,等.延续性护理对乳腺癌术后化疗患者生活质量与 健康知识水平的影响[J].医学信息,2018,31(16):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
　LIU Man,LIMA Qian-qian,XU Run-run,et al.Effect of Continuous Nursing on Quality of Life and Health Knowledge of Postoperative Chemotherapy Patients with Breast Cancer[J].Journal of Medical Information,2018,31(18):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
[9]满枋霖,葛俊宏,林晓月,等.p21活化激酶在乳腺癌中的作用研究[J].医学信息,2019,32(06):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]
　MAN Fang-lin,GE Jun-hong,LIN Xiao-yue,et al.The Role of p21 Activated Kinase in Breast Cancer[J].Journal of Medical Information,2019,32(18):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]
[10]张天竺,宁 勇.长链非编码RNA调控乳腺癌发生发展的研究进展[J].医学信息,2019,32(12):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]
　ZHANG Tian-zhu,NING Yong.Advances in Research on Long-chain Non-coding RNA Regulation of Breast Cancer Development[J].Journal of Medical Information,2019,32(18):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]

更新日期/Last Update: 2019-09-15